Perception of Hormonal Replacement Therapy Among Patients Aged 11 to 17 Years (THS)

December 18, 2025 updated by: University Hospital, Strasbourg, France

Current Knowledge and Perceptions of Hormone Replacement Therapy Among Patients Aged 11 to 18 Years, and Their Parents, Treated for Hypogonadism at the Strasbourg University Hospital

To establish a current knowledge and perception of patients and their parents regarding HRT in order to assess the needs that can promote understanding and adherence to treatment by implementing therapeutic education workshops

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • France
      • Strasbourg, France, 67091
        • Recruiting
        • Service de Gynécologie et obstétrique - CHU de Strasbourg - France
        • Contact:
        • Principal Investigator:
          • Mathilda KRETZ, MD
        • Principal Investigator:
          • Margot MALHERBET, MD
        • Sub-Investigator:
          • Sylvie ROSSIGNOL, MD, PhD
        • Sub-Investigator:
          • François BREZIN, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Female patients aged 11 to 18 years treated at the University Hospital of Strasbourg for central or peripheral hypogonadism with the initiation of hormone replacement therapy

Description

Inclusion Criteria:

  • Female patients aged 11 to 18 years
  • Treated at the University Hospital of Strasbourg for central or peripheral hypogonadism with the initiation of hormone replacement therapy

Exclusion Criteria:

- Inability to provide the subject with clear information (difficulties understanding the subject, language barrier, illiteracy, etc.)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of patients' knowledge about the composition of hormonal treatment for female hypogonadism
Time Frame: Up to 7 months
The aim is to assess the knowledge of patients aged 11 to 18 about the composition of hormone treatment for female hypogonadism using a questionnaire.
Up to 7 months
Assessment of patients' knowledge regarding the effects of hormonal treatment for female hypogonadism
Time Frame: Up to 7 months
The aim is to assess the knowledge of patients aged 11 to 18 years about the effects of hormone treatment for female hypogonadism using a questionnaire.
Up to 7 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Strasbourg, France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 23, 2025

Primary Completion (Estimated)

February 1, 2026

Study Completion (Estimated)

February 1, 2026

Study Registration Dates

First Submitted

December 18, 2025

First Submitted That Met QC Criteria

December 18, 2025

First Posted (Actual)

January 5, 2026

Study Record Updates

Last Update Posted (Actual)

January 5, 2026

Last Update Submitted That Met QC Criteria

December 18, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 9620 (Other Identifier: CTEP)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Female Hypogonadism

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe